These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 7516423

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.
    Hino K, Sainokami S, Shimoda K, Iino S, Wang Y, Okamoto H, Miyakawa Y, Mayumi M.
    J Med Virol; 1994 Mar; 42(3):299-305. PubMed ID: 7516422
    [Abstract] [Full Text] [Related]

  • 4. Hepatitis C virus markers in patients with long-term biochemical and histological remission of chronic hepatitis.
    Saracco G, Abate ML, Baldi M, Calvo PL, Manzini P, Brunetto MR, Oliveri F, Kuo G, Chien D, Houghton M.
    Liver; 1994 Apr; 14(2):65-70. PubMed ID: 7515141
    [Abstract] [Full Text] [Related]

  • 5. Significance of IgG and IgM HCV antibody secretion in vitro in patients with chronic hepatitis C: correlation with disease activity and response to interferon-alpha.
    Löhr H, Nagel C, Dienes HP, Simpson B, Michel G, Goergen B, Meyer zum Büschenfelde KH, Gerken G.
    Hepatology; 1994 Dec; 20(6):1383-9. PubMed ID: 7526999
    [Abstract] [Full Text] [Related]

  • 6. Immunoglobulin M and A antibodies to hepatitis C core antigen in chronic hepatitis C virus infection.
    Lau GK, Lesniewski R, Johnson RG, Davis GL, Lau JY.
    J Med Virol; 1994 Sep; 44(1):1-4. PubMed ID: 7528259
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. IgM and IgA antibodies generated against hepatitis C virus core antigen in patients with acute and chronic HCV infection.
    Sato S, Fujiyama S, Tanaka M, Goto M, Taura Y, Kawano S, Sato T, Yasuo H.
    Dig Dis Sci; 1994 Sep; 39(9):2022-31. PubMed ID: 7521823
    [Abstract] [Full Text] [Related]

  • 9. Long-term follow-up study of serum IgM antibody to hepatitis C virus (HCV), HCV replication, and liver disease outcome in chronic hepatitis C.
    Quiroga JA, Herrero M, Castillo I, Navas S, Pardo M, Carreño V.
    J Infect Dis; 1994 Sep; 170(3):669-73. PubMed ID: 7521377
    [Abstract] [Full Text] [Related]

  • 10. The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferon.
    Negro F, Abate ML, Mondardini A, Baldi M, Leandro G, Lombardi S, Wolfe L, Ryff JC, Verme G, Brunetto MR.
    J Viral Hepat; 1995 Sep; 2(4):171-4. PubMed ID: 7489343
    [Abstract] [Full Text] [Related]

  • 11. Significance of IgM anti-HCV core level in chronic hepatitis C.
    Papatheodoridis GV, Delladetsima JK, Katsoulidou A, Sypsa V, Albrecht M, Michel G, Hatzakis A, Tassopoulos NC.
    J Hepatol; 1997 Jul; 27(1):36-41. PubMed ID: 9252071
    [Abstract] [Full Text] [Related]

  • 12. IgM antibody response in acute hepatitis C viral infection.
    Clemens JM, Taskar S, Chau K, Vallari D, Shih JW, Alter HJ, Schleicher JB, Mimms LT.
    Blood; 1992 Jan 01; 79(1):169-72. PubMed ID: 1309424
    [Abstract] [Full Text] [Related]

  • 13. The significance of immunoglobulin M antibody response to hepatitis C virus core protein in patients with chronic hepatitis C.
    Yuki N, Hayashi N, Ohkawa K, Hagiwara H, Oshita M, Katayama K, Sasaki Y, Kasahara A, Fusamoto H, Kamada T.
    Hepatology; 1995 Aug 01; 22(2):402-6. PubMed ID: 7543432
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection.
    Urushihara A, Sodeyama T, Matsumoto A, Tanaka E.
    J Med Virol; 1994 Apr 01; 42(4):348-56. PubMed ID: 7519250
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Monitoring antibody titers to recombinant Core-NS3 fusion polypeptide is useful for evaluating hepatitis C virus infection and responses to interferon-alpha therapy.
    Park YM, Byun BH, Choi JY, Bae SH, Kim BS, So HS, Ryu WS.
    J Korean Med Sci; 1999 Apr 01; 14(2):165-70. PubMed ID: 10331562
    [Abstract] [Full Text] [Related]

  • 20. Variations of serum IgG subclass levels in hepatitis C virus infection during interferon-alpha therapy.
    Musset L, Ghillani P, Lunel F, Cacoub P, Cresta P, Frangeul L, Rosenheim M, Preud'homme JL.
    Immunol Lett; 1997 Jan 01; 55(1):41-5. PubMed ID: 9093880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.